Trials / Completed
CompletedNCT01290497
Efficacy and Safety of 3 Different Dosage Regimens of Hyaluronic Acid in Patients With Knee Osteoarthritis (OA)
Pilot, Unicentre, Randomized, Parallel, Controlled Study to Evaluate the Efficacy and Safety of Three Different Intraarticular Dosage Regimens of Adant® in Patients With Osteoarthritis of the Knee
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Tedec-Meiji Farma, S.A. · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The main objective is the comparison of three different dosage regimens of hyaluronic acid in the treatment of osteoarthritis of the knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyaluronic acid 5 x 2.5 ml | 5 intraarticular administration of Adant® 2.5ml with one week interval between administrations (standard treatment) |
| DRUG | Hyaluronic acid 1 x 5 ml | 1 intraarticular administration of Adant® 5ml |
| DRUG | Hyaluronic acid 2 x 5 ml | 2 intraarticular administration of Adant® 5ml with a two-week interval between administrations. |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-10-01
- Completion
- 2011-11-01
- First posted
- 2011-02-07
- Last updated
- 2014-03-03
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01290497. Inclusion in this directory is not an endorsement.